23/03/2023 - General information
The Associació Catalana de Gestors Esportius Professionals has recognized the international projection of the Laboratory. The Associació Catalana de Gestors Esportius Professionals (ACGEP) has awarded the Catalonia Prize for Sports Management on a national or international level to the Catalonian Anti-Doping Laboratory of the Hospital del Mar Medical Research Institute. The award recognizes the role of the Laboratory in projecting Catalonia to the world, its professionalism and its contribution to a cleaner sport. It was also highlighted that it is one of the thirty laboratories accredited in the world by the World Anti-Doping Agency to carry out doping controls on athletes, and that it works for clean sport in various national and international events.
18/01/2023 - General information
The Integrated Pharmacology and Systems Neurosciences Research Group of the Hospital del Mar Medical Research Institute has just published a study in Neurobiology of Disease, in which it highlights the role of the CDK5 protein as a possible marker of early psychosis. Furthermore, this protein is modulated by cannabis use. This paves the way for possible future treatments based on CDK5 expression.
Més informació "Possible biomarker for early psychosis identified"
20/12/2022 - General information
The Board of Trustees of the Spanish Psychiatry and Mental Health Foundation has chosen Dr. Víctor Pérez, head of the Psychiatry Department of the Hospital del Mar and coordinator of the Mental Health Research Group of the Hospital del Mar Medical Research Institute, as the new president of the organization. This appointment comes after Dr. Perez left his position as president of the executive committee of the Spanish Society of Psychiatry and Mental Health. As the highest representative of the foundation, Dr. Pérez will be responsible for representing the entity, chairing the meetings of its board of trustees and executing the agreements reached. The aim of its activity is to contribute to the knowledge, development and improvement of psychiatry and mental health and the disciplines that are linked to it.
Més informació "Dr. Víctor Pérez will chair the Spanish Foundation of Psychiatry and Mental Health."
01/12/2022 - General information
The first EU-wide STAR treatment registry is now open! STOPSTORM is now accepting anonymized data from our 30 partner organizations across 8 European countries. Later, we will expand this to even more centers across the EU. STOPSTORM aims to collect data from over 300 patients into the registry by 2025. These data will establish the indication, safety and efficacy of STAR for the treatment for Ventricular Tachycardia. What is STAR treatment? STAR is a non-invasive radiotherapy technique used to treat dangerously fast heart rhythm, called ventricular tachycardia, or VT. A similar radiotherapy technique has been used for a decade to treat lung cancer.
30/11/2022 - General information
The head of the Colon and Rectal Surgery Unit in the Surgery Department at Hospital del Mar and a researcher in the Cancer Research Programme at the Hospital del Mar Medical Research Institute received this professional accolade on 28 November. Dr. Marta Pascual, head of the Colon and Rectal Surgery Unit in the Surgery Service at Hospital del Mar and a researcher in the Cancer Research Programme at the Hospital del Mar Medical Research Institute, was one of the people honoured through the Official College of Doctors of Barcelona (Col·legi Oficial de Metges de Barcelona; COMB) Professional Excellence Award.
18/11/2022 - General information
A team of researchers from the Hospital del Mar Medical Research Institute has created a model for predicting individual breast cancer risk that could be used to create personalised breast cancer screening strategies. The research, presented at the 13th European Breast Cancer Conference, could make breast screening programmes more effective and ultimately improve survival rates. It could also mean fewer people suffering from 'false positives' (when screening tests indicate cancer, but other tests show there is none) and 'overdiagnosis' (when people are diagnosed and treated for a cancer that is extremely slow growing and has not caused any problems in their lives).
15/12/2022 - General information
The study, led by Dr. Xavier Nogués, has received one of the two biomedical research grants awarded by this organization, with a total endowment of 650,000 euros. The award ceremony took place in Madrid on December 14. A project to identify the factors that affect the risk of developing a state of fragility, headed by Dr. Xavier Nogués, director of the Clinical Translational Research Program at the Hospital del Mar Medical Research Institute and head of the Internal Medicine Department at the Hospital del Mar, has received one of the two grants for biomedical research awarded by the Francisco Soria Melguizo Foundation. These grants total 650,000 euros and were awarded on December 14 at a ceremony held at the Royal National Academy of Pharmacy in Madrid.
30/09/2022 - General information
An international collaborative study involving the Hospital del Mar Medical Research Institute and the Hospital del Mar has analyzed data from over 200,000 stroke patients and more than two million control individuals from five different ancestries. This study has associated 89 genes, of which 69 were previously unknown, with stroke and its subtypes. The research provides crucial insights to guide future biological investigations into the processes leading to this condition. Additionally, it reveals that some of these genes could potentially serve as targets for drugs to prevent or treat this disease. It also offers genetic prediction tools, improved and validated for the first time in non-European populations, to guide the development of new drugs.
07/11/2022 - General information
At the same time, the head of the Haematological Cytology section of the Pathology Service of the Hospital del Mar and researcher at the Hospital del Mar Medical Research Institute, is secretary of the board of directors of the Spanish Group for Haematological Cytology and also holds the same position in the Spanish Group of Myelodysplastic Syndromes.
03/11/2022 - General information
On 3 November, the 36 projects selected by the La Marató Foundation Board of Trustees, at the proposal of the Scientific Advisory Committee, were made public. Of these, four are led by researchers from Hospital del Mar and the IMIM, and the centres are participating in two others. La Marató de TV3 i Catalunya Ràdio has selected six projects that involve Hospital del Mar and the Hospital del Mar Medical Research Institute. These will receive funding from the La Marató 2021 call for grants, which is dedicated to mental health. In total, 36 proposals from 81 research teams have been selected to receive a share of the more than 12.1 million euros raised in the latest edition of the programme. The IMIM-Hospital del Mar is one of the centres with the most projects selected from the 150 proposals submitted.
Servei de Comunicació:
Marta Calsina Freixas(ELIMINAR)
Tel:
(+34) 93 316 06 80
Doctor Aiguader, 88
08226 Barcelona
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
